Glycolytic Reprogramming | List of Frontiers open access articles

Review

Published on 07 Oct 2025

Glycolytic reprogramming during microglial polarization in neurological diseases

in Multiple Sclerosis and Neuroimmunology

Xiaoting Li
Congcong Fang
Yina Li
Xiaoxing Xiong
Xu Xu
Lijuan Gu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1648887

5,242 views
2 citations

Original Research

Published on 22 Aug 2023

Glycolytic reprogramming in macrophages and MSCs during inflammation

in Molecular Innate Immunity

Xueping Li
Huaishuang Shen
Mao Zhang
Victoria Teissier
Ejun Elijah Huang
Qi Gao
Masanori Tsubosaka
Masakazu Toya
Junichi Kushioka
Chima V. Maduka

Frontiers in Immunology

doi 10.3389/fimmu.2023.1199751

23,529 views
51 citations

Original Research

Published on 27 Nov 2025

DANCR promotes septic cardiomyopathy by enhancing macrophage glycolytic reprogramming via the IGF2BP2/HK2 axis

in Epigenomics and Epigenetics

Chunhui Ma
Shaoyu Liu
Yu Zhao
Hong Liu
Xuguang Zhang

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2025.1628915

1,144 views

Brief Research Report

Published on 06 Jan 2026

Glycolytic reprogramming of resident alveolar macrophages contributes to reduced SOCS3 secretion in non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Jennifer M. Speth
Mikel D. Haggadone
Marc Peters-Golden

Frontiers in Immunology

doi 10.3389/fimmu.2025.1708467

1,055 views

Review

Published on 25 Jul 2024

Revisiting the role of hypoxia-inducible factors and nuclear factor erythroid 2-related factor 2 in regulating macrophage inflammation and metabolism

in Adaptive & Innate Immunity in Infection

Kenneth K. Y. Ting

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1403915

4,143 views
10 citations

Original Research

Published on 25 Aug 2022

Suppression of FOXP3 expression by the AP-1 family transcription factor BATF3 requires partnering with IRF4

in T Cell Biology

Preston R. Arnold
Mou Wen
Lei Zhang
Yuanlin Ying
Xiang Xiao
Xiufeng Chu
Guangchuan Wang
Xiaolong Zhang
Zhuyun Mao
Aijun Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2022.966364

6,828 views
15 citations

Review

Published on 04 Sep 2025

Harnessing glycolysis in gastric cancer: molecular targets, therapeutic strategies, and clinical horizons

in Cancer Immunity and Immunotherapy

Zexing Shan
Yefu Liu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1628937

5,526 views
2 citations

Original Research

Published on 10 Dec 2021

Hematopoietic Cell-Specific SLC37A2 Deficiency Accelerates Atherosclerosis in LDL Receptor-Deficient Mice

in Lipids in Cardiovascular Disease

Qingxia Zhao
Zhan Wang
Allison K. Meyers
Jennifer Madenspacher
Manal Zabalawi
Qianyi Zhang
Elena Boudyguina
Fang-Chi Hsu
Charles E. McCall
Cristina M. Furdui

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.777098

5,301 views
4 citations

Original Research

Published on 18 Jul 2022

Inhibition of Glycolysis Impairs Retinoic Acid-Inducible Gene I–Mediated Antiviral Responses in Primary Human Dendritic Cells

in Virus and Host

Alessandra Zevini
Enrico Palermo
Daniele Di Carlo
Magdalini Alexandridi
Serena Rinaldo
Alessio Paone
Francesca Cutruzzola
Marilena P. Etna
Eliana M. Coccia
David Olagnier

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2022.910864

5,356 views
13 citations

Original Research

Published on 16 Sep 2021

Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis

in Respiratory Pharmacology

Weimou Chen
Jinming Zhang
Wenshan Zhong
Yuanyuan Liu
Ye Lu
Zhaojin Zeng
Haohua Huang
Xuan Wan
Xiaojing Meng
Fei Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2021.744826

11,540 views
49 citations

Systematic Review

Published on 14 Jan 2025

Research progresses and hotspots on glucose metabolic reprogramming in breast cancer: a bibliometric analysis over the past two decades

in Cancer Metabolism

Lei Huang
Wenyue Zhao
Lamei Sun
Dong Niu
Xiaodan Zhu
Chunhui Jin

Frontiers in Oncology

doi 10.3389/fonc.2024.1493996

2,657 views
1 citation

Original Research

Published on 08 Apr 2019

FcγR-TLR Cross-Talk Enhances TNF Production by Human Monocyte-Derived DCs via IRF5-Dependent Gene Transcription and Glycolytic Reprogramming

in Antigen Presenting Cell Biology

Willianne Hoepel
Melissa Newling
Lisa T. C. Vogelpoel
Lathees Sritharan
Ivo S. Hansen
Martien L. Kapsenberg
Dominique L. P. Baeten
Bart Everts
Jeroen den Dunnen

Frontiers in Immunology

doi 10.3389/fimmu.2019.00739

9,634 views
34 citations

Original Research

Published on 22 Apr 2025

MIF tautomerase inhibitor TE-11 prevents inflammatory macrophage activation and glycolytic reprogramming while reducing leukocyte migration and improving Crohn’s disease-like colitis in male mice

in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders

Eszter Vámos
Viola Bagóné Vántus
Péter Deák
Nikoletta Kálmán
Eva Maria Sturm
Barsha Baisakhi Nayak
Lilla Makszin
Tamás Loránd
Ferenc Jr Gallyas
Balázs Radnai

Frontiers in Immunology

doi 10.3389/fimmu.2025.1558079

6,138 views
1 citation

Mini Review

Published on 15 Sep 2025

Metabolic regulation of Th9 cell differentiation: insights for IL-9-driven diseases

in Inflammation

Swetha Peesari
Jeremy P. McAleer

Frontiers in Immunology

doi 10.3389/fimmu.2025.1672072

3,160 views
2 citations

Original Research

Published on 12 Nov 2025

CELF1 promotes aerobic glycolysis and an aggressive phenotype in ER-positive breast cancer via GLUT1 regulation

in Cancer Genetics and Oncogenomics

Jinyu Li
Ning Wang
Jianlei Bi
Meihua Guo
Bingbing Xu
Gena Huang

Frontiers in Genetics

doi 10.3389/fgene.2025.1687066

1,910 views

Original Research

Published on 05 Nov 2025

Identification of glycolysis-related clusters and immune cell infiltration in hepatic fibrosis progression using machine learning models and experimental validation

in Inflammation

Guanglin Xiao
Zhiling Deng
Ke Qiu
Aoyi Li
Xingyue Yi
Hong Ren

Frontiers in Immunology

doi 10.3389/fimmu.2025.1684937

2,175 views

Articles

Glycolytic reprogramming during microglial polarization in neurological diseases

Glycolytic reprogramming in macrophages and MSCs during inflammation

DANCR promotes septic cardiomyopathy by enhancing macrophage glycolytic reprogramming via the IGF2BP2/HK2 axis

Glycolytic reprogramming of resident alveolar macrophages contributes to reduced SOCS3 secretion in non-small cell lung cancer

Revisiting the role of hypoxia-inducible factors and nuclear factor erythroid 2-related factor 2 in regulating macrophage inflammation and metabolism

Suppression of FOXP3 expression by the AP-1 family transcription factor BATF3 requires partnering with IRF4

Harnessing glycolysis in gastric cancer: molecular targets, therapeutic strategies, and clinical horizons

Hematopoietic Cell-Specific SLC37A2 Deficiency Accelerates Atherosclerosis in LDL Receptor-Deficient Mice

Inhibition of Glycolysis Impairs Retinoic Acid-Inducible Gene I–Mediated Antiviral Responses in Primary Human Dendritic Cells

Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis

Research progresses and hotspots on glucose metabolic reprogramming in breast cancer: a bibliometric analysis over the past two decades

FcγR-TLR Cross-Talk Enhances TNF Production by Human Monocyte-Derived DCs via IRF5-Dependent Gene Transcription and Glycolytic Reprogramming

MIF tautomerase inhibitor TE-11 prevents inflammatory macrophage activation and glycolytic reprogramming while reducing leukocyte migration and improving Crohn’s disease-like colitis in male mice

Metabolic regulation of Th9 cell differentiation: insights for IL-9-driven diseases

CELF1 promotes aerobic glycolysis and an aggressive phenotype in ER-positive breast cancer via GLUT1 regulation

Identification of glycolysis-related clusters and immune cell infiltration in hepatic fibrosis progression using machine learning models and experimental validation